Ischemia modified albumin changes - review and clinical implications. - Wikidata - wikimedia - TriplyDB

Ischemia modified albumin changes - review and clinical implications.

Ischemia modified albumin changes - review and clinical implications.

http://www.wikidata.org/entity/Q37810261

about

Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome Effect of curcumin against oxidation of biomolecules by hydroxyl radicals Clinical significance of ischemia-modified albumin in the diagnosis of doxorubicin-induced myocardial injury in breast cancer patients.The elevated copper binding strength of amyloid-β aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaques Paraoxonase 1 in chronic kidney failure Potential blood biomarkers for stroke.Evaluation of serum ischemia modified albumin levels in acute rheumatic fever before and after therapy.Ischemia-modified albumin levels in children with chronic liver disease.Correlation of ischemia-modified albumin levels and histopathologic findings in experimental ovarian torsion.Role of ethyl pyruvate in systemic inflammatory response and lung injury in an experimental model of ruptured abdominal aortic aneurysm.The effects of spinal, inhalation, and total intravenous anesthetic techniques on ischemia-reperfusion injury in arthroscopic knee surgery.Ischemia modified albumin can predict necrosis at incarcerated hernias.The role of ischemia modified albumin in acute pulmonary embolism.Role of ischemia-modified albumin in patients with acute decompensated heart failure.Ischemia modified albumin in early neonatal sepsis.Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers.Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.Evaluation of maternal serum ischemia modified albumin and total antioxidant status in ectopic pregnancy.Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.Changes in ischemia-modified albumin in myocardial toxicity induced by anthracycline and docetaxel chemotherapy.The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease.Haemostatic risk factors in dyslipidemic rabbits: role of 10-dehydrogingerdione as a new hypolipemic agent.An Overview of Celiac Disease in Childhood Type 1 Diabetes Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding

P2860

Q28468289-1843B662-D514-40EF-BBCE-17A4E7B02FB9 Q33862472-E416041D-E0F4-428B-9488-198A765B66CD Q34157415-86F56C3F-906B-4540-B677-C6322FD7D626 Q34617929-174AA7E8-971C-437A-B7F3-271B26632D55 Q35041318-7CCDF4E3-EF38-49A7-9ADB-4942DFA1CA4E Q36553193-190CDEDF-9DB6-44A6-BA63-114F74B74DC7 Q38004498-6F669EB1-7402-44A9-B753-BA37DE6AB089 Q38042459-BD0696F2-2830-4E68-AB2B-1C9DCB2B5B81 Q40242748-8BF34872-A2CB-4167-B527-D5B3BD17C638 Q41552571-F2D96C5D-058B-4B50-837A-95FA4F987568 Q41838001-96E3B2AD-6615-4B53-8E24-27C0A5FE69A3 Q41921117-6417FB29-34B8-4023-88E8-001E544C28B6 Q41962124-F619F57D-144C-43FF-A372-726E873F9066 Q41988208-5B55FC04-9AF9-47AC-AEF3-8C77A84784E7 Q42231055-C623BCA4-1EB5-40E1-9A90-615329B465A4 Q42318485-44654934-D47C-423F-9B09-2E96456F6913 Q44789621-3F8BF231-EFDB-45A2-B973-3B3808424E00 Q46414850-AF69D33E-FF23-4D57-9F54-AFB841AB8E8B Q46460675-CD386A9B-979B-4D71-BE04-84BFF056CDD1 Q47238481-4B9ABF72-5324-4EFE-8399-1978DE4C0421 Q47367683-9E498CC0-D4AA-4542-BBE1-1EFA74B92F52 Q47969502-2A4CA228-76EC-4801-9200-C44CEE194A21 Q50514189-06442936-3050-4FEB-BC65-B08E3825FC59 Q53819348-F4F0A271-0944-4BFE-947B-D4968120D13E Q56891624-5698FF97-A82E-4B21-88EB-46E32CB39C2D Q58805331-BC18F0F5-6105-40FF-9D42-0CA15ADBE9F8

P2860

Ischemia modified albumin changes - review and clinical implications.

http://www.wikidata.org/entity/Q37810261

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Ischemia modified albumin changes - review and clinical implications.

@en

Ischemia modified albumin changes - review and clinical implications.

@nl

type

label

Ischemia modified albumin changes - review and clinical implications.

@en

Ischemia modified albumin changes - review and clinical implications.

@nl

prefLabel

Ischemia modified albumin changes - review and clinical implications.

@en

Ischemia modified albumin changes - review and clinical implications.

@nl

P1433

Q37810261-4137C9B5-624B-45CF-8669-CB09AF05D22F

P1476

Q37810261-08570380-3224-43CE-B71D-370044BD56D3

P2093

Q37810261-9CFC3F90-7C87-48A6-82FF-834FDDF24271

Q37810261-C2D5EE32-8254-4F2C-9D9F-E887133F2BF1

Q37810261-DEF7AA6D-D52B-48F6-B21E-EF7D8CAC5E72

P2860

Q37810261-00C73919-3E27-4E26-B2E8-6D9CA92635FC

Q37810261-0274D808-F4CA-4E33-A2AB-771F86688D8F

Q37810261-03AA5410-6988-4F33-8BBD-4FEE1B6830E9

Q37810261-05FBC91A-E92B-4F5C-A6F0-D539058426C2

Q37810261-0C7DC1BD-869E-4F7D-B52F-9C1231F29B4D

Q37810261-16358F6C-77B2-4FE5-A71D-A0F9AAE37CAF

Q37810261-17351758-18A2-4EC1-B058-738AC6621133

Q37810261-1CC9FF2E-0FB6-4348-ADCF-E73741AA3936

Q37810261-2FA497E8-69C6-41D3-9E22-D76B1B379317

Q37810261-3C62A24C-D82A-47AE-B3E2-AAC9C9D3EA3E

P304

Q37810261-BD3A95B7-EAB6-47E2-B42B-FDD88CB687F3

P31

Q37810261-523CA20E-43D8-4EAB-8BD8-09430105A20B

P356

Q37810261-753E4F9F-907A-4600-9FE7-2290D792E010

P433

Q37810261-7CF515E0-DC3B-4BEE-9B14-3404D38EC063

P478

Q37810261-CE155E86-A2CB-4356-A776-55A037A7D9D2

P577

Q37810261-0A2FFDB3-EDB1-4CEC-81E3-B64CD5C2845E

P698

Q37810261-48C9EE4C-C5B7-437D-9AAF-DC3445774CF8

P356

P1433

Clinical Chemistry and Laboratory Medicine

P1476

Ischemia modified albumin changes - review and clinical implications.

@en

P2093

Eftihia Sbarouni

http://www.w3.org/2001/XMLSchema#string

Panagiota Georgiadou

http://www.w3.org/2001/XMLSchema#string

Vassilis Voudris

http://www.w3.org/2001/XMLSchema#string

P2860

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome

Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome

Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes.

The influence of exercise upon cardiac biomarkers: a practical guide for clinicians and scientists.

Biomarkers of cardiovascular damage and dysfunction--an overview.

Utility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department.

The PRIMA study: presentation ischaemia-modified albumin in the emergency department.

Derivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain.

Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction.

Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction

P304

177-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/CCLM.2011.037

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21083441

http://www.w3.org/2001/XMLSchema#string